Quarterly projections for the "virx stock forecast" highlight probable resistance challenges near $17.20 if sector sentiment cools. Price reaction to economic data will remain pivotal in the short term. Jul 25, 2025 · According to the research reports of 2 Wall Street equities research analysts, the average twelve-month stock price forecast for Viracta Therapeutics is $1.13, with a high forecast of $2.00 and a low forecast of $0.25. CSX Stock Rally: Strong Options Flow, Analyst Price Targets Risk-analysis frameworks applied to the "virx stock forecast" recommend attention to volatility metrics. Beta stands at 1.32, indicating higher fluctuation risk compared to the S&P 500, attractive to high-risk investors.